FDC
Back to Income Statement
|
FDC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹267 Cr | ₹305 Cr | ₹194 Cr | ₹216 Cr | ₹301 Cr |
What is the latest Consolidated Net Profit of FDC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹267 Cr |
| Mar2024 | ₹305 Cr |
| Mar2023 | ₹194 Cr |
| Mar2022 | ₹216 Cr |
| Mar2021 | ₹301 Cr |
How is Consolidated Net Profit of FDC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹267 Cr | -12.55 | |
| Mar2024 | ₹305 Cr | 57.22 | |
| Mar2023 | ₹194 Cr | -10.33 | |
| Mar2022 | ₹216 Cr | -28.19 | |
| Mar2021 | ₹301 Cr | - | |
Compare Consolidated Net Profit of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,560.8 Cr | -2.7% | -6.3% | -16.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -2.7% |
-6.3% |
-16.9% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses